G9705 – Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented

Long description

Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented

Short description

Ajcc br ca stg ib

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2017

Last change

January 1, 2017 – No change

Nearby G codes

• G9697 – Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator
• G9698 – Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., cost of treatment or lack of insurance)
• G9699 – Long-acting inhaled bronchodilator not prescribed, reason not otherwise specified
• G9700 – Patients who use hospice services any time during the measurement period
• G9701 – Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established
• G9702 – Patients who use hospice services any time during the measurement period
• G9703 – Episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date
• G9704 – Ajcc breast cancer stage i: t1 mic or t1a documented
• G9706 – Low (or very low) risk of recurrence, prostate cancer
• G9707 – Patient received hospice services any time during the measurement period
• G9708 – Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy
• G9709 – Hospice services used by patient any time during the measurement period
• G9710 – Patient was provided hospice services any time during the measurement period
• G9711 – Patients with a diagnosis or past history of total colectomy or colorectal cancer
• G9712 – Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis
• G9713 – Patients who use hospice services any time during the measurement period